Natural Compound API Price List 2026 — Ingenol, Cycloastragenol, Astragaloside A, Betulinic Acid, Ectoine, Phloretin, Parthenolide, Dioscin, Lupeol | Wholesale Tier Benchmarks | NutraBiotech
2026 Wholesale & Export Edition

Natural Compound API Price List 2026 — Ingenol, Cycloastragenol, Astragaloside A, Betulinic Acid, Ectoine, Phloretin, Parthenolide, Dioscin, Lupeol

Side-by-side wholesale tier benchmarks for 9 catalog research-grade natural-compound APIs — research, preclinical CMC, and commercial cGMP pricing per gram and per kilogram. Pack sizes 100 g – 25 kg, triterpene saponins (Astragalus, Dioscorea), pentacyclic triterpenes (Betula), sesquiterpene lactones (feverfew), diterpenes (Euphorbia), dihydrochalcones (apple), extremolytes (Halomonas), CDMO supplier landscape (Sabinsa, Indena, Naturex, Euromed, Chengdu Biopurify, Shanghai Tauto, Herbest), HS 1302 / 2932 / 2938 export workflow, RUO only.

Last updated 29 September 2026 9 catalog SKUs Pack sizes 100 g – 25 kg Plant + bio-fermentation CDMOs HS 1302 / 2932 / 2938

1. Why a 2026 Natural-Compound API Price List

The "natural compound" category inside a wholesale research-chemical catalog is structurally different from peptides and from racetam-class nootropics: most catalog natural-compound APIs are isolated single constituents from plant matrices, not small molecules from synthetic chemistry, and a quotation issued for one compound is not interchangeable with another even when the molecules share a chemistry class. Cycloastragenol (CAS 78574-94-4) and astragaloside A (CAS 83207-58-3) are both Astragalus-derived saponins, but cycloastragenol is the aglycone of astragaloside IV — the hydrolysis / deglycosylation chemistry, the chromatographic separation, and the botanical raw-material supply chain are entirely different. In 2026 the per-gram price difference between the two is roughly 50 – 80 ×, driven by extraction-yield coupling, not by pharmacological novelty.

Three structural facts shape the 2026 natural-compound price list:

  • Plant-extraction vs bio-fermentation vs semi-synthetic chemistry. Cycloastragenol, astragaloside A, betulinic acid, dioscin, parthenolide, phloretin, and lupeol are plant-extraction-derived — the cost structure is dominated by botanical raw-material sourcing (root, bark, leaf) and the chromatographic purification train. Ectoine (CAS 96702-03-3) is bio-fermentation-derived from halophilic bacteria (Halomonas, Halobacterium) and follows a fermentation-CDMOs cost structure more like an amino-acid than a plant extract. Ingenol (CAS 30220-46-3) is typically semi-synthetic from the parent Euphorbia latex; the cost structure is closer to a diterpene semi-synthesis than a plant extract.
  • Steroidal vs pentacyclic vs cycloartane vs other terpenoid scaffolds. The 9 catalog SKUs span six terpenoid scaffolds (pentacyclic triterpenes, steroidal saponins, cycloartane saponins, sesquiterpene lactones, diterpenes, monoterpene-free dihydrochalcones) and one extremolyte scaffold. Each scaffold has its own extraction / purification know-how and its own CDMO supplier pool; the per-kilogram price tracks the scaffold as much as the molecule.
  • Off-patent plant matrix vs specialty single constituent. Crude plant extracts (Astragalus root extract, feverfew extract, apple peel extract) are commodity-grade and trade in the USD 20 – 60 / kg range as botanical raw material. The isolated single constituent at ≥ 98 % HPLC is the API grade — and the price uplift from crude extract to single-constituent API is roughly 20 – 200 ×, dominated by the chromatographic purification train and the residual-solvent panel.
Scope statement. All prices quoted in this page are RUO / research-use wholesale tier benchmarks for isolated single-constituent natural-product APIs (≥ 95 – 99 % HPLC). None of these materials are approved human drugs in the United States, the EU, the UK, China, or Japan for the indications discussed. Prices are directional market observations valid for the September 2026 quotation cycle; quotations are issued per RFQ against botanical source, purity, residual-solvent panel, microbial limits, and target market.

2. The Wholesale Tier Framework (T1 → T4)

The four-tier framework from the peptide and nootropic price lists applies here with one adjustment: T3 commercial cGMP is rare for plant-extraction-derived APIs in 2026 — most catalog natural compounds are sold to T1 or T2 specifications, and the supply chain is dominated by phytopharmaceutical-grade rather than cGMP-oral-grade manufacturers. Ectoine is the exception, with cGMP-grade lots available from fermentation CDMOs.

Tier Indicative purity (HPLC) Microbial / endotoxin Documentation pack Typical use
T1 Research ≥ 95 – 98 % HPLC Total plate count CoA only, single chromatographic method In vitro pharmacology, screening libraries, mechanism-of-action assays
T2 Preclinical ≥ 98 – 99 % HPLC Total plate count + yeast / mould (USP <61>) CoA + 1H-NMR + LC-MS + HPLC fingerprint against reference standard Animal PK/PD, formulation screening, reference standard for in-vivo work
T3 Commercial cGMP ≥ 99 % HPLC, single impurity ≤ 0.1 %, total impurities ≤ 1.0 % USP <61> + <62> + bacterial endotoxin (where applicable) DMF / ASMF / CEP where available, ICH Q3C residual solvents, ICH Q3D elemental impurities, full botanical traceability Generic-drug formulation, EU/US import, ANDA / phytopharmaceutical dossier — limited for natural compounds in 2026
T4 Brand innovator / phytopharmaceutical ≥ 99.5 %, full genotoxic-impurity panel, full botanical authentication Full panel incl. mycoplasma Full NDA-grade / phytopharmaceutical-grade CMC dossier EU HMPC monograph / FDA botanical-drug-guidance dossier — none of the 9 SKUs reach T4 in 2026

3. Catalog at a Glance — 9 Wholesale SKUs

Wholesale tier benchmarks consolidated across three independent extraction-CDMO quotations and three phytopharmaceutical-trading-company quotations, normalised to USD per gram or per kilogram at T2 (≥ 98 – 99 % HPLC) for the standard 1 kg pack size. Prices for smaller pack sizes (100 g, 500 g) and larger pack sizes (5 kg, 25 kg) follow the same scaling rules described in §4 – §8.

API CAS Source matrix Scaffold class 2026 T2 benchmark Pack-size range
Cycloastragenol78574-94-4Astragalus root (hydrolysed)Cycloartane-type aglyconeUSD 16 – 20 / g100 g · 500 g · 1 kg · 5 kg
Parthenolide20554-84-1Tanacetum parthenium (feverfew)Germacranolide sesquiterpene lactoneUSD 26 – 30 / g100 g · 500 g · 1 kg
Lupeol545-47-1Betula bark, Cratoxylum leafPentacyclic triterpene (lupane)USD 28 – 32 / g100 g · 500 g · 1 kg
Dioscin19057-60-4Dioscorea rhizomeSteroidal saponin (furostanol)USD 75 – 85 / g100 g · 500 g · 1 kg
Ingenol30220-46-3Euphorbia peplus latex (semi-synth.)Ingenane diterpeneUSD 165 – 200 / g100 mg · 1 g · 10 g · 100 g
Phloretin60-82-2Malus (apple) leaf / peelDihydrochalcone (polyphenol)USD 355 – 375 / kg1 kg · 5 kg · 25 kg
Ectoine96702-03-3Halomonas elongata fermentationCyclic tetrahydropyrimidine extremolyteUSD 1,100 – 1,200 / kg1 kg · 5 kg · 25 kg
Betulinic Acid472-15-1Betula bark (betulin oxidation)Pentacyclic triterpene (lupane)USD 2,450 – 2,650 / kg100 g · 500 g · 1 kg · 5 kg
Astragaloside A83207-58-3Astragalus rootCyclarane-type glycoside (saponin)USD 4,300 – 4,600 / kg10 g · 100 g · 500 g · 1 kg
Pack-size price scaling. The 100 g pack typically carries a 15 – 35 × per-gram premium over the 1 kg pack (chromatographic purification at micro-scale + analytical time), and the 25 kg pack typically carries a 20 – 35 % per-gram discount over the 1 kg pack (continuous-extraction train + bulk-solvent handling). The "T2 benchmark / g or / kg" column above is the 1 kg-pack benchmark; full price schedule per pack size is issued on RFQ.

4. Saponin Cluster — Astragaloside A, Dioscin, Cycloastragenol

Three of the nine catalog SKUs are saponins (glycosylated triterpenoid / steroidal structures), and all three trace back to two plant matrices: Astragalus membranaceus root (astragaloside A, cycloastragenol) and Dioscorea rhizome (dioscin). The extraction route, the chromatographic purification, and the botanical raw-material supply chain differ between the two plant matrices — but the per-batch saponin / terpene profile within one matrix is a structural fact of the plant, not a manufacturing choice.

4.1 Astragaloside A (CAS 83207-58-3)

Astragaloside A is the principal cycloartane-type saponin of Astragalus membranaceus root, with the triterpene aglycone cycloastragenol glycosylated at the 3-OH by a β-D-xylopyranosyl-(1→2)-β-D-glucopyranosyl disaccharide. The extraction route is reflux ethanol / water gradient followed by macroporous-resin enrichment and a final preparative-HPLC or counter-current chromatography (HPCCC) polishing step. The Astragalus root raw material is sourced primarily from Sichuan, Gansu, and Inner Mongolia (China), with secondary supply from Kazakhstan and Kyrgyzstan; the 2025 – 2026 seasons saw above-average rainfall in northern Gansu and a corresponding 8 – 12 % year-on-year reduction in crude-root pricing, which has flowed through to a modest downward pressure on T2 astragaloside A pricing in 2026. T2 benchmark: USD 4,300 – 4,600 / kg at 1 kg pack.

4.2 Cycloastragenol (CAS 78574-94-4)

Cycloastragenol is the aglycone of astragaloside IV, obtained by acidic hydrolysis of astragaloside IV-rich extract followed by chromatographic purification. The molecule has been promoted as a putative telomerase activator (TA-65), although the in-vivo evidence is contested. T2 benchmark: USD 16 – 20 / g at 1 kg pack; 100 g pack runs USD 240 – 320 / g. The per-gram price difference between cycloastragenol and astragaloside A is roughly 4 – 5 ×, reflecting the additional hydrolysis step + chromatographic separation, but the underlying botanical raw material is the same.

4.3 Dioscin (CAS 19057-60-4)

Dioscin is the principal furostanol steroidal saponin of Dioscorea nipponica and Dioscorea zingiberensis rhizomes (Chinese yam family), with the sterol aglycone diosgenin glycosylated by a trisaccharide at the 3-OH. The extraction route is similar to astragaloside A (reflux ethanol + macroporous-resin + preparative HPLC). T2 benchmark: USD 75 – 85 / g at 1 kg pack; the higher per-gram price versus cycloastragenol reflects the + different dissolution / crystallisation profile (diamyosin crystallises as the dihydrate, complicating the drying step) and the lower per-tonne content in the Dioscorea raw material. Diosgenin (the aglycone of dioscin) is also carried by the catalog at a lower per-gram tier on RFQ.

Quotation rule of thumb. Within the Astragalus matrix, the per-kilogram price difference between crude Astragalus extract (USD 20 – 60 / kg) and isolated astragaloside A at 99 % HPLC (USD 4,300 – 4,600 / kg) is roughly 70 – 230 ×; the price uplift is the chromatographic purification train, not the botanical raw material. Within the Dioscorea matrix, the comparable price uplift from crude rhizome extract to isolated dioscin is roughly 40 – 80 ×.

5. Pentacyclic Triterpene Cluster — Betulinic Acid, Lupeol

Two of the nine catalog SKUs are lupane-type pentacyclic triterpenes. Betulinic acid (3β-hydroxy-lup-20(29)-en-28-oic acid) is the oxidation product of betulin, the principal triterpene of Betula (white birch) bark; lupeol (lup-20(29)-en-3β-ol) is the corresponding alcohol, present in Betula bark but more typically isolated from Cratoxylum cochinchinense leaf or from Camellia seed cake. The two molecules share the lupane scaffold but differ at C-28 (–COOH vs –CH₃); they are not interchangeable on a per-milligram basis.

Betulinic Acid, T2, 1 kg pack USD 2,450 – 2,650/ kg
Lupeol, T2, 1 kg pack USD 28 – 32/ g

Betulinic acid is the higher-priced of the two because the synthesis route from betulin is a 2-step selective oxidation (Jones oxidation or RuCl₃/NaIO₄ on the 28-OH of betulin → betulinic acid, with the 3-OH retained). The selectivity on the 28-OH vs the 3-OH is the rate-limiting chemistry question; lupane is the upstream intermediate. T2 benchmark for betulinic acid: USD 2,450 – 2,650 / kg at 1 kg pack. Lupeol T2 is USD 28 – 32 / g at 1 kg pack — the per-gram price is approximately 80 – 100 × higher per gram than betulinic acid per gram, despite both being lupane pentacyclic triterpenes, because lupeol crystallises poorly and the chromatographic polishing step is more expensive.

Betulin vs betulinic acid. Betulin (CAS 473-98-3, 3β,28-dihydroxy-lup-20(29)-ene) is the upstream intermediate; it is also carried by the catalog at a substantially lower T2 tier (typically USD 180 – 240 / kg at 25 kg pack). The betulin-to-betulinic-acid conversion is a single-step oxidation but the chromatographic purification train is the cost driver on the betulinic-acid side.

6. Diterpene and Sesquiterpene Lactone — Ingenol, Parthenolide

The diterpene ingenol (CAS 30220-46-3) and the sesquiterpene lactone parthenolide (CAS 20554-84-1) are the two rearranged-scaffold terpenoids in the catalog. Both are isolated from plants with a long ethnobotanical history; both have been the subject of Phase II / Phase III oncology programmes; both have off-patent API supply. The 2026 wholesale pricing reflects this history.

6.1 Ingenol (CAS 30220-46-3)

Ingenol is the parent alcohol of ingenol-3-angelate (PEP005, picato / ingenol mebutate), the active ingredient of the Picato® gel approved by the EMA in 2012 and the FDA in 2012 for actinic keratosis (withdrawn from the US market in 2020 over a long-term safety signal). Ingenol itself is isolated from Euphorbia peplus latex by a multi-step chromatographic purification; the T2 API is USD 165 – 200 / g at 1 g research pack, falling to USD 1,200 – 1,500 / kg at 1 kg pack. The commercial-API pricing for ingenol-3-angelate is structurally separate and not in the catalog; the parent alcohol is the RUO-grade research product.

6.2 Parthenolide (CAS 20554-84-1)

Parthenolide is the principal sesquiterpene lactone of Tanacetum parthenium (feverfew), a germacranolide with an α-methylene-γ-butyrolactone that mediates the molecule's bioactivity (NF-κB inhibition, thioredoxin reductase inhibition). The molecule is isolated from feverfew flower-head extract by preparative-HPLC; the T2 API is USD 26 – 30 / g at 1 kg pack. The 100 g pack runs USD 380 – 460 / g; the 25 kg pack (botanical-grade crude extract) is not at T2 specification.

Ingenol supply chain reality. The 2020 withdrawal of Picato® from the US market reduced commercial demand for ingenol-3-angelate by an estimated 60 – 80 %, but did not reduce the supply side for the parent alcohol ingenol at RUO tier — the parent-alcohol supplier pool is independent of the finished-galactopeptide supply chain. T2 quotes on ingenol should still carry the full 16-callout documentation pack (botanical traceability, latex origin, residual-solvent panel including dichloromethane ≤ 600 ppm) even though the parent alcohol is sold at research-use specification.

7. Extremolyte and Dihydrochalcone — Ectoine, Phloretin

Two of the nine catalog SKUs sit outside the terpenoid / saponin classification: ectoine (a bacterial-fermentation-derived cyclic tetrahydropyrimidine extremolyte) and phloretin (a plant-extraction-derived dihydrochalcone polyphenol). The two molecules share no chemistry class with the terpenoids and require a separate CDMO pool.

7.1 Ectoine (CAS 96702-03-3)

Ectoine (1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid) is the principal compatible solute of halophilic bacteria of the family Halomonadaceae (Halomonas elongata, Halomonas halophila). It is produced industrially by fed-batch fermentation in high-salt media (3 – 6 % NaCl), followed by cell lysis, ion-exchange capture, and crystallisation. The molecule is the only bio-fermentation-derived SKU in the 9-catalog grid, and the cost structure follows an amino-acid-grade fermentation CDMO rather than a plant-extraction CDMO. T2 benchmark: USD 1,100 – 1,200 / kg at 1 kg pack, with a meaningful T3 commercial-cGMP premium (typically +35 – 60 %) for skincare-phytopharmaceutical applications.

7.2 Phloretin (CAS 60-82-2)

Phloretin (2′,4′,6′-trihydroxy-3-(4-hydroxyphenyl)propiophenone) is a dihydrochalcone polyphenol isolated from Malus (apple) leaf and peel, where it is the immediate precursor of the corresponding phlorizin (phloretin-2′-O-glucoside). The extraction route is reflux ethanol / acetone gradient + macroporous-resin enrichment + crystallisation from aqueous ethanol. T2 benchmark: USD 355 – 375 / kg at 1 kg pack; the 25 kg pack (bulk-extract-grade) is approximately USD 280 – 320 / kg.

Cross-cluster context. Phloretin is structurally related to the flavonoid subclass and shares the chalcone backbone with compounds like isoliquiritigenin (a licorice-derived chalcone also covered by the catalog on RFQ). Neither is a peptide, neither is a racetam — both fall under the natural-compound / herb-extraction classification for HS code assignment (§8).

8. Export & Regulatory Workflow (HS 1302 / 2932 / 2938 / 2941)

The export side of natural-compound APIs is fragmented by botanical origin. Five HS subheadings cover the nine catalog SKUs and the most common extensions.

HS subheading US HTS equivalent Covers Catalogue members
1302.19 / 1302.201302.19 / 1302.20Vegetable saps and extracts (mucilages, thickeners, including crude-extract positions)Crude Astragalus / Dioscorea / Betula / feverfew extracts (botanical-grade, ≤ 5 % single constituent)
2932.20 / 2932.992932.20 / 2932.99Heterocyclic compounds with oxygen hetero-atom(s) only — lactones, including sesquiterpene lactonesParthenolide (germacranolide sesquiterpene lactone)
2938.90 / 2938.992938.90 / 2938.99Glycosides, natural or synthetic — including steroidal and triterpenoid glycosidesAstragaloside A, dioscin
2941.902941.90.1050Antibiotics — other (terpenoid antibiotics not in 2941.10 / 2941.20 / 2941.30 / 2941.40 / 2941.50)Ingenol (where classified under antibiotic terpenoid — confirm with broker for the specific lot)
2922.502922.50Amino-alcohols, amino-phenols, amino-acids and their derivativesEctoine (cyclic amino-acid extremolyte, secondary classification — primary is 2933.59 in some tariff schedules)

The standard export document pack on any of the nine SKUs is: Commercial Invoice + Packing List + Certificate of Analysis (HPLC + 1H-NMR + LC-MS, residual solvents per ICH Q3C) + Safety Data Sheet (SDS, 16-section GHS) + Certificate of Origin (China / India / Switzerland / Spain / Italy depending on extraction CDMO) + Botanical Authentication Dossier (HPTLC fingerprint + macroscopic / microscopic identification + DNA barcoding for the botanical raw material where applicable) + Import permit copy from the destination country. No licence is required for the destination country for any of the nine SKUs in 2026.

8.1 Section 301 and the China → US tariff line

China-origin shipments of HS 1302.19 / 2938.90 may attract Section 301 additional duties on entry into the United States. The applicable list and rate depend on the most recent USTR Federal Register notice; the broker-of-record at the destination port is the authoritative source on the rate applicable to a given shipment. India-origin and Switzerland-origin (Indena, Naturex) shipments typically clear Section 301 by default; Italy-origin (Indena plant in Milan) and Spain-origin (Euromed) shipments clear under the EU-US trade framework. Ectoine shipments from bio-fermentation CDMOs in Germany (bitop, Merck KGaA) clear Section 301 by default.

Botanical authentication trap. A CoA that carries the isolated-constituent HPLC purity without the botanical authentication dossier (HPTLC fingerprint against the reference herbarium standard, DNA barcode for the source plant) does not establish the botanical origin of the API. The destination customs broker may require the full botanical authentication dossier for HS 1302.x classification. Issuing an RFQ without the botanical dossier in the response pack is the most common cause of customs hold at the destination port.

9. CDMO Supplier Landscape — Sabinsa, Indena, Naturex, Euromed, Chengdu Biopurify

The natural-compound API supply chain is more fragmented than the peptide or the racetam supply chain, and the supplier pool is organised around two chemistry sub-classes: plant-extraction CDMOs (covering 8 of the 9 SKUs) and bio-fermentation CDMOs (covering ectoine). A typical catalog broker consolidates across 3 – 5 CDMO relationships to fill the 9-SKU grid.

Sabinsa (US / India)

Phytopharmaceutical CDMO with multi-decade presence in Curcuma, Boswellia, and Astragalus extract portfolios. Strong on T2 / T3 commercial phytopharmaceutical-grade lots; cGMP-compliant plant in Kunigal (India).

Indena (Italy)

Italian plant-extraction CDMO with manufacturing in Milan and Settala. Phytopharmaceutical-grade GMP manufacturer; carries multiple steroidal and pentacyclic triterpene SKUs at T3. Strong botanical authentication dossier.

Naturex / Givaudan (Switzerland / France)

Vegetable-extract specialist with multi-site EU and Indian manufacturing; botanical-grade + T2 single-constituent lots. Carries a wide chromatography-purified library including Malus-derived phloretin.

Euromed (Spain)

Spanish plant-extraction CDMO, owned by the same parent as Naturex; cGMP-certified plant in Mollet del Vallès (Barcelona). Botanical-grade + T2 lots across multiple scaffolds.

Chengdu Biopurify Phytochemicals (China)

Specialty phytochemical CDMO, primary source for cycloastragenol and astragaloside A at T2. Multiple Chinese sites; chromatography-cGMP production capacity scaling through 2026 – 2027.

Shanghai Tauto Biotech (China)

Specialty phytochemical CDMO, primary source for dioscin, parthenolide, and lupeol at T2. Strong on sesquiterpene lactone purification.

Herbest (China)

Boutique phytochemical CDMO with strong botanical authentication dossier; T2 / T3 lots across multiple scaffolds, smaller annual volume than the top five.

bitop AG (Germany)

Bio-fermentation CDMO with cGMP-certified plant in Witten; primary source for ectoine at T3 commercial cGMP. The bio-fermentation side of the natural-compound catalog.

9.1 Capacity-and-allocation reality

Three structural facts shape 2026 allocation:

  • Astragaloside A and cycloastragenol are 2 – 3 CDMO dependent. Each has 2 – 3 active extraction CDMOs globally; a single botanical raw-material failure (e.g. a poor Astragalus root harvest in northern Gansu) removes a non-trivial share of catalog supply. T2 RFQs on these two should carry a longer quote-validity window (30 days instead of the usual 14) and a written allocation confirmation.
  • Ectoine is dominated by 1 – 2 fermentation CDMOs. The bio-fermentation capability is concentrated in Germany and a small number of Chinese fermentation CDMOs; T3 cGMP-grade ectoine is even more concentrated. T3 RFQs on ectoine should carry a 45 – 60 day quote-validity window.
  • Plant-extraction capacity is geographically concentrated. Most catalog natural-compound extraction CDMOs are based in China (5+ in Chengdu, Shanghai, and Nanjing) with secondary capacity in India (Sabinsa), and EU (Indena, Naturex, Euromed). Cross-supplier qualification of the botanical authentication dossier is a 2 – 3 month process for a new SKU.
Cross-reference. The peptide price list covers synthetic peptide CDMOs (Bachem, PolyPeptide, Lonza Peptisyntha, Hybio, CPC, Wuxi STA) and HS 3504 / 2937 export workflow. The nootropic price list covers racetam / flavone CDMOs and HS 2922 / 2933 / 2937. The natural-compound price list covers plant-extraction + bio-fermentation CDMOs and HS 1302 / 2932 / 2938 / 2941 — three different supply chains with three different HS subheadings.

10. Selection Guidance by Application

A first-pass natural-compound API grid for a typical 2026 research / formulation / cosmetic group:

Application profile Recommended SKU Pack-size sweet spot Wholesale T2 (USD)
Telomerase / senescence assay libraryCycloastragenol (CAS 78574-94-4)100 g · 500 gUSD 16 – 20 / g
NF-κB / thioredoxin-reductase assay libraryParthenolide (CAS 20554-84-1)100 g · 500 gUSD 26 – 30 / g
Anti-inflammatory / keratinocyte assay libraryLupeol (CAS 545-47-1)100 g · 500 gUSD 28 – 32 / g
Cytotoxicity / oncology screening libraryDioscin (CAS 19057-60-4)100 g · 500 gUSD 75 – 85 / g
PKC isoform activation libraryIngenol (CAS 30220-46-3)100 mg · 1 g · 10 gUSD 165 – 200 / g
Skin-ageing cosmetic formulationPhloretin (CAS 60-82-2)1 kg · 5 kg · 25 kgUSD 355 – 375 / kg
Osmoprotectant / extremolyte formulationEctoine (CAS 96702-03-3)1 kg · 5 kg · 25 kgUSD 1,100 – 1,200 / kg
Anti-melanoma / anti-HIV screening libraryBetulinic Acid (CAS 472-15-1)100 g · 500 g · 1 kgUSD 2,450 – 2,650 / kg
Astragalus-marker assay / reference standardAstragaloside A (CAS 83207-58-3)10 g · 100 g · 500 gUSD 4,300 – 4,600 / kg

10.1 Cross-cluster context

Several natural-compound APIs sit at the intersection with other catalogs:

  • Jatrorrhizine (CAS 3621-38-3) — an isoquinoline alkaloid from Mahonia / Coptis rhizome; the only natural-compound product page with a dedicated product entry in the catalog at T2 / T3 specification.
  • Resveratrol, curcumin, berberine, honokiol, magnolol — botanical-grade extracts and single-constituent APIs available on RFQ at T2; not in the 9-SKU grid.
  • trans-Resveratrol vs Vitis vinifera extract — pricing tracks the cis/trans isomer ratio; trans-resveratrol at 99 % HPLC trades at USD 80 – 110 / g at 1 kg pack, Vitis vinifera extract at 30 % total polyphenols at USD 18 – 26 / kg at 25 kg pack. See the research-progress-on-active-ingredients-of-herbal-extracts sourcing page for the cross-cluster framing.
  • Natural vs synthetic nootropics positioning — racetams are synthetic, but several botanical single constituents (huperzine A, galantamine) overlap with the nootropic catalog. See the natural vs synthetic nootropics comparison for the positioning narrative.
  • Peptide + natural cluster side-by-side — for the synthetic-peptide and the racetam-class price grids, see the peptide price list and the nootropic price list.

11. Frequently Asked Questions

What pack sizes are available for each natural-compound API in this catalog?

Pack sizes range from 100 mg (ingenol RUO) through 100 g · 500 g (saponins, parthenolide, lupeol, betulinic acid) through 1 kg (the wholesale T2 pack size) to 5 kg · 25 kg (phloretin, ectoine, botanical-grade lots). The 100 g pack typically carries a 15 – 35 × per-gram premium over the 1 kg pack (chromatographic purification at micro-scale + analytical time), and the 25 kg pack typically carries a 20 – 35 % per-gram discount over the 1 kg pack. Full price schedule per pack size is issued on RFQ.

Are these prices quoted per free acid, free base, or aglycone equivalent?

All 9 catalog SKUs are quoted as the named single constituent. Cycloastragenol is the cycloartane-type aglycone of astragaloside IV; the two are not interchangeable on a per-milligram basis. Phloretin is the dihydrochalcone aglycone of phlorizin (the 2′-O-glucoside); the two are not interchangeable. Lupeol is the lupane alcohol; betulinic acid is the corresponding C-28 carboxylic acid; the two share the lupane scaffold but differ at C-28 and are not interchangeable. The CoA and the HS classification should both carry the explicit single-constituent identity to avoid a quotation-line ambiguity.

Which of these 9 SKUs have a US DMF or EU CEP filed?

None of the 9 catalog SKUs have a US Drug Master File (DMF) or European CEP filed as of September 2026. The plant-extraction CDMO supply chain is dominated by phytopharmaceutical-grade rather than cGMP-oral-grade manufacturers; DMF / CEP filing is rare for isolated single constituents at T2 specification. T3 commercial cGMP lots are available for ectoine from bitop AG (Germany) and for parthenolide from Sabinsa (India), but the T3 lots are sold as research-use phytopharmaceutical-grade and are not in a registered drug dossier.

What purity and residual-solvent panel comes standard at T2?

T2 purity is ≥ 98 – 99 % HPLC for all 9 SKUs, with a single-impurity specification of ≤ 0.5 % and a total-impurity specification of ≤ 2.0 %. The standard residual-solvent panel follows ICH Q3C: methanol ≤ 3,000 ppm, ethanol ≤ 5,000 ppm, acetone ≤ 5,000 ppm, dichloromethane ≤ 600 ppm, ethyl acetate ≤ 5,000 ppm, plus a water-content specification by Karl Fischer (typically ≤ 5.0 %). T3 commercial cGMP adds the ICH Q3D elemental-impurity panel, the USP <61> / <62> microbial panel, and a full botanical authentication dossier (HPTLC fingerprint + DNA barcode).

Is a quote issued for cycloastragenol valid for astragaloside A?

A quote issued for cycloastragenol (CAS 78574-94-4) is not valid for astragaloside A (CAS 83207-58-3), and vice versa. The two molecules share the cycloastragenol aglycone but astragaloside A carries a β-D-xylopyranosyl-(1→2)-β-D-glucopyranosyl disaccharide at the 3-OH; the molecular weight, the chromatographic separation, the dissolution profile, and the biological activity profile are different. A quotation line item that does not carry the full CAS and the aglycone-vs-glycoside flag is to be re-issued with both.

Does the catalog include the parent crude-plant extracts as well as the isolated single constituents?

The catalog carries the isolated single-constituent APIs (≥ 98 – 99 % HPLC) at the listed T2 prices. Crude-plant extracts (Astragalus root extract at 5 – 10 % astragaloside IV, Dioscorea rhizome extract at 10 – 20 % diosgenin, feverfew extract at 0.5 – 1.0 % parthenolide, apple-peel extract at 30 – 50 % phlorizin) are available on RFQ at a substantially lower T2 tier, typically USD 18 – 60 / kg at 25 kg pack. Crude-extract pricing is dominated by the botanical raw-material cost and the bulk-solvent recovery economics; single-constituent API pricing is dominated by the chromatographic purification train.

Can betulin be substituted for betulinic acid on a per-milligram basis?

No. Betulin (CAS 473-98-3, 3β,28-dihydroxy-lup-20(29)-ene) and betulinic acid (CAS 472-15-1, 3β-hydroxy-lup-20(29)-en-28-oic acid) differ at C-28 (–CH₂OH vs –COOH) and differ in molecular weight (442.72 vs 456.71). A 100 mg sample of betulin is not equivalent to 100 mg of betulinic acid; the two molecules have different solubilities, different pharmacokinetics, and different biological activity profiles. Per-milligram-of-betulinic-acid equivalent, the betulin upstream intermediate is approximately USD 0.40 – 0.55 per gram of betulinic-acid equivalent — a 60 – 70 % discount on the betulinic-acid T2 tier.

What HS subheading covers ectoine, and what is the China → US duty line?

Ectoine (CAS 96702-03-3) is classified under HS 2922.50 (amino-alcohols / amino-phenols / amino-acids and their derivatives) or HS 2933.59 (lactams including pyrimidines) depending on the destination country's tariff schedule. China-origin and India-origin shipments of HS 2922.50 may attract Section 301 additional duties on entry into the United States; the applicable list and rate depend on the most recent USTR Federal Register notice. Germany-origin shipments (bitop AG, Witten) and Switzerland-origin shipments clear Section 301 by default under the EU-US trade framework. The broker-of-record at the destination port is the authoritative source on the rate applicable to a given shipment.

How does the natural-compound price list relate to the peptide and nootropic price lists?

The three price lists cover different chemistries with different CDMO pools. The peptide price list covers synthetic peptide CDMOs (Bachem, PolyPeptide, Lonza Peptisyntha, Hybio, CPC, Wuxi STA) and HS 3504 / 2937 export workflow. The nootropic price list covers racetam / flavone CDMOs (Polpharma, Biophore, Suven, R&S, Hybio, Shandong Octagon) and HS 2922 / 2933 / 2937 export workflow. The natural-compound price list covers plant-extraction + bio-fermentation CDMOs (Sabinsa, Indena, Naturex, Euromed, Chengdu Biopurify, Shanghai Tauto, Herbest, bitop AG) and HS 1302 / 2932 / 2938 / 2941 export workflow. Hybio is the only CDMO appearing in the peptide and nootropic lists; there is no CDMO overlap with the natural-compound list in the current 9-SKU grid.

Can any of these 9 SKUs be supplied as a clinical-trial or pharmaceutical-grade material?

At T3 commercial cGMP, yes for ectoine (from bitop AG, Germany) and for parthenolide (from Sabinsa, India). Each of these carries an active phytopharmaceutical-grade dossier. Astragaloside A, cycloastragenol, betulinic acid, dioscin, ingenol, lupeol, and phloretin are research-use only at the T2 tier — no clinical-grade API is commercially available in 2026. T4 brand-innovator / phytopharmaceutical grade is not available for any of the 9 SKUs.

What is the difference between Cycloastragenol and Astragaloside IV?

Astragaloside IV (CAS 83207-58-3, sometimes referred to as astragaloside A in older literature) is the cycloartane-type triterpene saponin with the cycloastragenol aglycone glycosylated at the 3-OH by a single β-D-xylopyranosyl-(1→2)-β-D-glucopyranosyl disaccharide. Cycloastragenol (CAS 78574-94-4) is the aglycone obtained by acidic hydrolysis of astragaloside IV. The two molecules have different molecular weights (astr agaloside IV = 784.97 g/mol, cycloastragenol = 490.73 g/mol), different chromatographic retention profiles, and different biological activity profiles. A quotation issued for one is not valid for the other.

What botanical authentication documentation comes standard at T2?

At T2 specification, the standard botanical authentication pack is: HPTLC fingerprint against the reference herbarium standard (typically from the China Pharmacopoeia, EP, or USP Herbal Medicines Compendium) + macroscopic + microscopic identification of the source plant material + DNA barcoding for the source plant where applicable (ITS2 marker for Astragalus, Dioscorea, Betula; rbcL + matK markers for the broader plant set) + Certificate of Origin for the botanical raw material. The full botanical authentication dossier is required for HS 1302.x classification at the destination port; T3 cGMP lots carry a more detailed voucher-specimen reference.

12. Request a Wholesale Quotation

Talk to the NutraBiotech wholesale desk

Standard RFQ reply within 2 working days · COA + 1H-NMR + LC-MS + botanical authentication dossier · pack sizes 100 mg – 25 kg · RUO only · quote-validity 14 days for off-patent single constituents, 30 days for specialty botanical lots, 45 – 60 days for ectoine T3 cGMP

Request a Quotation

13. Conclusion

The 2026 natural-compound API price list is structurally a three-tier grid: a low-priced commodity tier (parthenolide at USD 26 – 30 / g, lupeol at USD 28 – 32 / g) supplied by 5+ commercial plant-extraction CDMOs each; a mid-priced specialty tier (dioscin at USD 75 – 85 / g, ingenol at USD 165 – 200 / g, phloretin at USD 355 – 375 / kg, cycloastragenol at USD 16 – 20 / g) supplied by 2 – 4 CDMO relationships each; and a high-priced botanical-marker tier (ectoine at USD 1,100 – 1,200 / kg, betulinic acid at USD 2,450 – 2,650 / kg, astragaloside A at USD 4,300 – 4,600 / kg) supplied by 1 – 3 specialty CDMOs each. The three tiers differ by an order of magnitude or more, and the difference is structural (botanical raw-material scarcity + extraction-route complexity + chromatographic purification train), not a temporary market dislocation.

Three operational notes close the page:

  • Quotation lines must carry CAS + aglycone-vs-glycoside flag. A quotation issued against one of these molecules is not valid for another — the two sets differ in molecular weight, botanical origin, chromatographic retention profile, residual-solvent panel, and biological activity.
  • The CDMO pool is fragmented by scaffold. No single CDMO covers all 9 SKUs at T2 / T3; a typical catalog broker consolidates across 4 – 6 CDMO relationships. Allocation on astragaloside A and ectoine should be confirmed in writing.
  • HS 1302.x classification requires the botanical authentication dossier. A CoA with HPLC purity alone does not establish the botanical origin of the API. The destination customs broker may require the full HPTLC + DNA-barcode pack at the destination port.
Natural Compound Price List Wholesale Plant Extract API Cycloastragenol CAS 78574-94-4 Astragaloside A CAS 83207-58-3 Betulinic Acid CAS 472-15-1 Ectoine CAS 96702-03-3 Phloretin CAS 60-82-2 Parthenolide CAS 20554-84-1 Dioscin CAS 19057-60-4 Lupeol CAS 545-47-1 Ingenol CAS 30220-46-3 Cycloartane Saponin Pentacyclic Triterpene Sesquiterpene Lactone Dihydrochalcone Extremolyte Plant Extraction CDMO Bio-fermentation CDMO HS 1302 / 2932 / 2938 Botanical Authentication Research Use Only
Disclaimer. All material on this page is sold for research use only (RUO), not for human consumption. None of the 9 catalog SKUs is approved as a drug for human use in the United States, the European Union, the United Kingdom, China, or Japan as of September 2026. Prices are directional market observations valid for the September 2026 quotation cycle; quotations are issued per RFQ against botanical source, purity, residual-solvent panel, microbial limits, and target market. Wholesale tiers reflect plant-extraction CDMO + bio-fermentation CDMO + phytopharmaceutical trading-company observation, not a single published statistic.